Lyme disease vaccine found to be safe and effective in clinical trial

A vaccine against Lyme disease has been shown to be safe and effective in a clinical trial and could be available by 2025.

Tens of thousands of people in the US and Europe are diagnosed each year with Lyme disease, which is transmitted by tick bites and can cause lifelong health problems like joint and nerve pain if it isn't treated early.

French company Valneva has developed a vaccine that works by stopping Lyme-causing bacteria in ticks from passing into people's bloodstreams when the ticks bite. It does this ...